Literature DB >> 19234303

Characterization of 3-ketosteroid 9{alpha}-hydroxylase, a Rieske oxygenase in the cholesterol degradation pathway of Mycobacterium tuberculosis.

Jenna K Capyk1, Igor D'Angelo, Natalie C Strynadka, Lindsay D Eltis.   

Abstract

KshAB (3-Ketosteroid 9alpha-hydroxylase) is a two-component Rieske oxygenase (RO) in the cholesterol catabolic pathway of Mycobacterium tuberculosis. Although the enzyme has been implicated in pathogenesis, it has largely been characterized by bioinformatics and molecular genetics. Purified KshB, the reductase component, was a monomeric protein containing a plant-type [2Fe-2S] cluster and FAD. KshA, the oxygenase, was a homotrimer containing a Rieske [2Fe-2S] cluster and mononuclear ferrous iron. Of two potential substrates, reconstituted KshAB had twice the specificity for 1,4-androstadiene-3,17-dione as for 4-androstene-3,17-dione. The transformation of both substrates was well coupled to the consumption of O(2). Nevertheless, the reactivity of KshAB with O(2) was low in the presence of 1,4-androstadiene-3,17-dione, with a k(cat)/K(m)(O(2)) of 2450 +/- 80 m(-1) s(-1). The crystallographic structure of KshA, determined to 2.3A(,) revealed an overall fold and a head-to-tail subunit arrangement typical of ROs. The central fold of the catalytic domain lacks all insertions found in characterized ROs, consistent with a minimal and perhaps archetypical RO catalytic domain. The structure of KshA is further distinguished by a C-terminal helix, which stabilizes subunit interactions in the functional trimer. Finally, the substrate-binding pocket extends farther into KshA than in other ROs, consistent with the large steroid substrate, and the funnel accessing the active site is differently orientated. This study provides a solid basis for further studies of a key steroid-transforming enzyme of biotechnological and medical importance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234303      PMCID: PMC2665117          DOI: 10.1074/jbc.M900719200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Steady-state kinetic characterization and crystallization of a polychlorinated biphenyl-transforming dioxygenase.

Authors:  N Y Imbeault; J B Powlowski; C L Colbert; J T Bolin; L D Eltis
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

2.  'Super bugs' for bioremediation.

Authors:  Kensuke Furukawa
Journal:  Trends Biotechnol       Date:  2003-05       Impact factor: 19.536

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  Structure of the terminal oxygenase component of angular dioxygenase, carbazole 1,9a-dioxygenase.

Authors:  Hideaki Nojiri; Yuji Ashikawa; Haruko Noguchi; Jeong-Won Nam; Masaaki Urata; Zui Fujimoto; Hiromasa Uchimura; Tohru Terada; Shugo Nakamura; Kentaro Shimizu; Takako Yoshida; Hiroshi Habe; Toshio Omori
Journal:  J Mol Biol       Date:  2005-08-12       Impact factor: 5.469

5.  Kinetic and Mössbauer studies on the mechanism of protocatechuic acid 4,5-oxygenase.

Authors:  R Zabinski; E Münck; P M Champion; J M Wood
Journal:  Biochemistry       Date:  1972-08-15       Impact factor: 3.162

Review 6.  Rieske business: structure-function of Rieske non-heme oxygenases.

Authors:  Daniel J Ferraro; Lokesh Gakhar; S Ramaswamy
Journal:  Biochem Biophys Res Commun       Date:  2005-09-08       Impact factor: 3.575

7.  Structure of an aromatic-ring-hydroxylating dioxygenase-naphthalene 1,2-dioxygenase.

Authors:  B Kauppi; K Lee; E Carredano; R E Parales; D T Gibson; H Eklund; S Ramaswamy
Journal:  Structure       Date:  1998-05-15       Impact factor: 5.006

8.  Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.

Authors:  Xinxin Yang; Eugenie Dubnau; Issar Smith; Nicole S Sampson
Journal:  Biochemistry       Date:  2007-07-14       Impact factor: 3.162

9.  Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis.

Authors:  Katherine C Yam; Igor D'Angelo; Rainer Kalscheuer; Haizhong Zhu; Jian-Xin Wang; Victor Snieckus; Lan H Ly; Paul J Converse; William R Jacobs; Natalie Strynadka; Lindsay D Eltis
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

10.  Structural investigations of the ferredoxin and terminal oxygenase components of the biphenyl 2,3-dioxygenase from Sphingobium yanoikuyae B1.

Authors:  Daniel J Ferraro; Eric N Brown; Chi-Li Yu; Rebecca E Parales; David T Gibson; S Ramaswamy
Journal:  BMC Struct Biol       Date:  2007-03-09
View more
  57 in total

1.  The conserved Rieske oxygenase DAF-36/Neverland is a novel cholesterol-metabolizing enzyme.

Authors:  Takuji Yoshiyama-Yanagawa; Sora Enya; Yuko Shimada-Niwa; Shunsuke Yaguchi; Yoshikazu Haramoto; Takeshi Matsuya; Kensuke Shiomi; Yasunori Sasakura; Shuji Takahashi; Makoto Asashima; Hiroshi Kataoka; Ryusuke Niwa
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.

Authors:  Suzanne T Thomas; Brian C VanderVen; David R Sherman; David G Russell; Nicole S Sampson
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

Review 3.  The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.

Authors:  Brian C VanderVen; Lu Huang; Kyle H Rohde; David G Russell
Journal:  Microbiol Spectr       Date:  2016-12

4.  Rhodococcus rhodochrous DSM 43269 3-ketosteroid 9alpha-hydroxylase, a two-component iron-sulfur-containing monooxygenase with subtle steroid substrate specificity.

Authors:  M Petrusma; L Dijkhuizen; R van der Geize
Journal:  Appl Environ Microbiol       Date:  2009-06-26       Impact factor: 4.792

5.  Structural and functional characterization of a ketosteroid transcriptional regulator of Mycobacterium tuberculosis.

Authors:  Adam M Crowe; Peter J Stogios; Israël Casabon; Elena Evdokimova; Alexei Savchenko; Lindsay D Eltis
Journal:  J Biol Chem       Date:  2014-11-18       Impact factor: 5.157

6.  Withdrawn

Authors: 
Journal:  Infect Disord Drug Targets       Date:  2012-11-16

Review 7.  Updating and curating metabolic pathways of TB.

Authors:  Richard A Slayden; Mary Jackson; Jeremy Zucker; Melissa V Ramirez; Clinton C Dawson; Rebecca Crew; Nicole S Sampson; Suzanne T Thomas; Neema Jamshidi; Peter Sisk; Ron Caspi; Dean C Crick; Michael R McNeil; Martin S Pavelka; Michael Niederweis; Axel Siroy; Valentina Dona; Johnjoe McFadden; Helena Boshoff; Jocelyne M Lew
Journal:  Tuberculosis (Edinb)       Date:  2013-02-01       Impact factor: 3.131

8.  Comparative genomic analysis of Mycobacterium neoaurum MN2 and MN4 substrate and product tolerance.

Authors:  Ling-Xia Xu; Hui-Lin Yang; Meng-An Kuang; Zong-Cai Tu; Xiao-Lan Wang
Journal:  3 Biotech       Date:  2017-06-29       Impact factor: 2.406

9.  A flavin-dependent monooxygenase from Mycobacterium tuberculosis involved in cholesterol catabolism.

Authors:  Carola Dresen; Leo Y-C Lin; Igor D'Angelo; Elitza I Tocheva; Natalie Strynadka; Lindsay D Eltis
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

10.  Engineered 3-Ketosteroid 9α-Hydroxylases in Mycobacterium neoaurum: an Efficient Platform for Production of Steroid Drugs.

Authors:  Hao-Hao Liu; Li-Qin Xu; Kang Yao; Liang-Bin Xiong; Xin-Yi Tao; Min Liu; Feng-Qing Wang; Dong-Zhi Wei
Journal:  Appl Environ Microbiol       Date:  2018-07-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.